QSI - NASDAQ

Quantum-Si incorporated

QSI·NASDAQ

$1.19

-4.0%

HealthcareBiotechnology

Quantum-Si incorporated, a life sciences company, develops a single molecule detection platform for sample preparation and sequencing. It offers a proprietary single molecule detection platform for use in semiconductor industry to field proteomics to enable next generation protein sequencing. The company was incorporated in 2013 is based in Guilford, Connecticut.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$235.41M

EPS-0.5100

P/E Ratio-2.33

Earnings Date08/04/2026

qsi

Total Liabilities and Equity

Last Annual Value

245.61M

3-Year CAGR

-14%

5-Year CAGR

43%

10-Year CAGR

21%

Adjust for Inflation

Quantum-Si incorporated Competitors Analysis of Total Liabilities and Equity

QSI · NASDAQ

Company	Total Liabilities and Equity	CAGR 3Y	CAGR 5Y	CAGR 10Y
Quantum-Si incorporated NASDAQ:QSI	245.61M	-6.3%	-13.4%	N/A
Aura Biosciences, Inc. NASDAQ:AURA	169.43M	-12.7%	1.1%	N/A
Rocket Pharmaceuticals, Inc. NASDAQ:RCKT	330.45M	-16.4%	-7.8%	9.8%
Corvus Pharmaceuticals, Inc. NASDAQ:CRVS	71.12M	16.0%	-8.3%	-6.6%
Gossamer Bio, Inc. NASDAQ:GOSS	172.25M	-18.0%	-12.9%	121.7%
Inhibrx Biosciences, Inc. NASDAQ:INBX	146.48M	-21.9%	-0.5%	21.3%
Lexicon Pharmaceuticals, Inc. NASDAQ:LXRX	184.99M	-6.9%	6.2%	-9.0%
Ocugen, Inc. NASDAQ:OCGN	43.52M	-12.3%	-16.3%	1.9%
Verastem, Inc. NASDAQ:VSTM	246.44M	18.1%	17.8%	11.4%
Prothena Corporation plc NASDAQ:PRTA	326.80M	-22.3%	-11.7%	-3.4%
I-Mab NASDAQ:IMAB	212.68M	-56.7%	-48.1%	N/A

Quantum-Si incorporated Fair Value Envelope

QSI · NASDAQ

Our analysis suggests that QSI has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $1.19, this represents a potential HIDDEN relative to our calculated worth for Quantum-Si incorporated.

HIDDEN

Intrinsic Value

Current Price: $1.19

Related Guides

Blog Categories

Continue your QSI research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.